In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

A new study has explored a potential link between a particular sleep pattern and the risk of Alzheimer’s disease ...

A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.

Roche is focusing on early diagnosis of Alzheimer's disease and will soon release its first blood-based biomarker for the ...

The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...

Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...